Stem cell transplant without toxic preparation successfully treats genetic disease

An antibody treatment developed at Stanford Medicine successfully prepared patients for stem cell transplants without toxic busulfan chemotherapy or radiation, a Phase I clinical trial has shown.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup